How effective is endoscopic third ventriculostomy in treating adult @entity1276 caused by XXXX ?

@entity1 @entity1276
OBJECTIVE: To evaluate the long-term efficacy of third ventriculostomies for adult @entity1 with @entity1276 caused by @entity1276 . METHODS: Eighteen of 64 @entity1 who underwent endoscopic third ventriculostomies (ETVs) between June 1991 and July 1995 were treated because of @entity1276 . All of these @entity1 accepted follow-up investigations, which were performed 3 months to 5 years after surgery. If hydrocephalic symptoms persisted, the patency of the ventriculostomy was investigated; in cases of open ventriculostomies, the @entity1 were offered shunt surgery. The effects of the shunt surgery were evaluated after 3 months. RESULTS: After ETV, nine of the @entity1 exhibited excellent improvements, two exhibited slight improvements, one displayed no change, and six demonstrated temporary improvements. The ventriculostomies were patent in all nine @entity1 who experienced less than excellent results. Subsequent ventriculoperitoneal shunt placement produced improvements for all seven @entity1 who accepted the surgery. CONCLUSION: In our experience, the long-term effectiveness of ETVs for adult @entity1 with noncommunicating @entity1276 was sufficient in only 50% of the cases. One-third of the @entity1 exhibited temporary improvements, lasting 1 to 12 months (average duration, 5 mo) after the ETVs, and then demonstrated deterioration to even worse clinical conditions, despite patent ventriculostomies. All @entity1 who did not exhibit permanent improvements after the ETVs benefited from shunt surgery. Efforts should be made to establish methods for the selection of @entity1 for ETV or ventriculoperitoneal shunt surgery.
